Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

NARecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Breast NeoplasmsBreast Cancer
Interventions
BEHAVIORAL

PACHA Program

Pharmacists in this group will complete the 85-minutes web-based training, schedule and realize at least 2 telephone consultations with participating women in their pharmacy (in the first month and 4 months after randomization) using standardized consultation guides based on the principles of motivational interviewing and, if necessary, the evidence-based web sheets about strategies to cope with side effects and other AET-related concerns. Women in this group will have access to a web site that includes video capsules to inform women about AET, evidence-based web sheets describing strategies to cope with side effects and other AET-related concerns, testimonies of women who had breast cancer and an AET and a list of resources available for women.

Trial Locations (1)

G1S 4L8

RECRUITING

Centre de recherche du CHU de Québec, Québec

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Quebec Breast Cancer Foundation

OTHER

lead

CHU de Quebec-Universite Laval

OTHER